Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BCSF
BCSF logo

BCSF Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Bain Capital Specialty Finance Inc (BCSF) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
12.370
1 Day change
0.08%
52 Week Range
16.000
Analysis Updated At
2026/06/18
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Bain Capital Specialty Finance Inc (BCSF) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, hedge funds are selling, and there are no significant positive catalysts or news to drive the stock upward. While the stock shows a slight chance of short-term gains, it lacks strong signals for long-term growth. Given the investor's profile and the current data, holding off on buying is the most prudent action.

Technical Analysis

The MACD histogram is negative (-0.0756) and contracting, RSI is neutral at 27.652, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 12.363, with resistance at 13.12. Overall, the technical indicators suggest a bearish trend.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
5

Positive Catalysts

  • NULL identified. No recent news or significant insider activity to suggest a positive catalyst.

Neutral/Negative Catalysts

  • Hedge funds are selling, with a 136.38% increase in selling activity over the last quarter. No significant insider buying, and technical indicators are bearish.

Financial Performance

No financial data available for analysis due to an error in the provided data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes available for review.

Wall Street analysts forecast BCSF stock price to rise
3 Analyst Rating
Wall Street analysts forecast BCSF stock price to rise
1 Buy
2 Hold
0 Sell
Moderate Buy
Current: 12.360
sliders
Low
14
Averages
14.83
High
16
Current: 12.360
sliders
Low
14
Averages
14.83
High
16
BofA
Neutral
downgrade
$13
AI Analysis
2026-03-09
Reason
BofA
Price Target
$13
AI Analysis
2026-03-09
downgrade
Neutral
Reason
BofA lowered the firm's price target on Bain Capital Specialty Finance to $13 from $14.50 and keeps a Neutral rating on the shares. The firm is adjusting forecasts for several business development companies following quarterly reports from the group.
Keefe Bruyette
Paul Johnson
Outperform
to
Outperform
downgrade
$16 -> $15
2026-03-03
Reason
Keefe Bruyette
Paul Johnson
Price Target
$16 -> $15
2026-03-03
downgrade
Outperform
to
Outperform
Reason
Keefe Bruyette analyst Paul Johnson lowered the firm's price target on Bain Capital Specialty Finance to $15 from $16 and keeps an Outperform rating on the shares. Bain Capital Specialty Finance had a "solid" quarter, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BCSF
Unlock Now

People Also Watch